• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚型特异性基因组改变为软组织肉瘤治疗确定新的靶点。

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.

机构信息

Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Nat Genet. 2010 Aug;42(8):715-21. doi: 10.1038/ng.619. Epub 2010 Jul 4.

DOI:10.1038/ng.619
PMID:20601955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2911503/
Abstract

Soft-tissue sarcomas, which result in approximately 10,700 diagnoses and 3,800 deaths per year in the United States, show remarkable histologic diversity, with more than 50 recognized subtypes. However, knowledge of their genomic alterations is limited. We describe an integrative analysis of DNA sequence, copy number and mRNA expression in 207 samples encompassing seven major subtypes. Frequently mutated genes included TP53 (17% of pleomorphic liposarcomas), NF1 (10.5% of myxofibrosarcomas and 8% of pleomorphic liposarcomas) and PIK3CA (18% of myxoid/round-cell liposarcomas, or MRCs). PIK3CA mutations in MRCs were associated with Akt activation and poor clinical outcomes. In myxofibrosarcomas and pleomorphic liposarcomas, we found both point mutations and genomic deletions affecting the tumor suppressor NF1. Finally, we found that short hairpin RNA (shRNA)-based knockdown of several genes amplified in dedifferentiated liposarcoma, including CDK4 and YEATS4, decreased cell proliferation. Our study yields a detailed map of molecular alterations across diverse sarcoma subtypes and suggests potential subtype-specific targets for therapy.

摘要

软组织肉瘤在美国每年导致约 10700 例诊断和 3800 例死亡,表现出显著的组织学多样性,有超过 50 种公认的亚型。然而,它们的基因组改变的知识是有限的。我们描述了对涵盖七个主要亚型的 207 个样本的 DNA 序列、拷贝数和 mRNA 表达的综合分析。经常发生突变的基因包括 TP53(多形性脂肪肉瘤的 17%)、NF1(黏液纤维肉瘤的 10.5%和多形性脂肪肉瘤的 8%)和 PIK3CA(黏液性/圆形细胞脂肪肉瘤或 MRC 的 18%)。MRC 中的 PIK3CA 突变与 Akt 激活和不良临床结局相关。在黏液纤维肉瘤和多形性脂肪肉瘤中,我们发现了影响肿瘤抑制基因 NF1 的点突变和基因组缺失。最后,我们发现,针对去分化脂肪肉瘤中扩增的几个基因(包括 CDK4 和 YEATS4)的短发夹 RNA(shRNA)敲低降低了细胞增殖。我们的研究提供了不同肉瘤亚型中分子改变的详细图谱,并提示了潜在的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/e60921a3bf62/nihms212743f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/0170d029a388/nihms212743f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/02f478233857/nihms212743f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/291b07b8a4fb/nihms212743f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/e60921a3bf62/nihms212743f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/0170d029a388/nihms212743f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/02f478233857/nihms212743f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/291b07b8a4fb/nihms212743f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066d/2911503/e60921a3bf62/nihms212743f4.jpg

相似文献

1
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.亚型特异性基因组改变为软组织肉瘤治疗确定新的靶点。
Nat Genet. 2010 Aug;42(8):715-21. doi: 10.1038/ng.619. Epub 2010 Jul 4.
2
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.软组织肉瘤的基因表达分析:恶性纤维组织细胞瘤的特征与重新分类
Mod Pathol. 2007 Jul;20(7):749-59. doi: 10.1038/modpathol.3800794. Epub 2007 Apr 27.
3
Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.46例多形性软组织肉瘤的细胞遗传学分析及其与形态学和临床特征的相关性:CHAMP研究组报告。染色体与形态学。
Genes Chromosomes Cancer. 1998 May;22(1):16-25. doi: 10.1002/(sici)1098-2264(199805)22:1<16::aid-gcc3>3.0.co;2-a.
4
Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.家族性软组织肉瘤中p53基因种系和肿瘤突变的分析
J Surg Oncol. 2007 Mar 15;95(4):347-50. doi: 10.1002/jso.20720.
5
Lipomatous tumors.脂肪瘤性肿瘤
Monogr Pathol. 1996;38:207-39.
6
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.端粒酶逆转录酶(TERT)启动子热点突变在黏液样脂肪肉瘤中反复出现,但在其他软组织肉瘤实体中罕见。
J Exp Clin Cancer Res. 2014 Apr 11;33(1):33. doi: 10.1186/1756-9966-33-33.
7
Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.去分化脂肪肉瘤和恶性纤维组织细胞瘤中β-连环蛋白的积聚及外显子3中的基因突变。
Arch Pathol Lab Med. 2002 Sep;126(9):1071-8. doi: 10.5858/2002-126-1071-CAAGMI.
8
Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.177例软组织肉瘤的诊断和预后基因表达特征:缺氧诱导转录谱表明转移潜能。
BMC Genomics. 2007 Mar 14;8:73. doi: 10.1186/1471-2164-8-73.
9
Spindle cell liposarcoma with a TRIO-TERT fusion transcript.具有 TRIO-TERT 融合转录本的梭形细胞脂肪肉瘤。
Virchows Arch. 2019 Sep;475(3):391-394. doi: 10.1007/s00428-019-02545-5. Epub 2019 Feb 22.
10
Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.炎症性恶性纤维组织细胞瘤和去分化脂肪肉瘤:组织学回顾、基因组概况以及MDM2和CDK4状态支持单一实体。
J Pathol. 2004 Jul;203(3):822-30. doi: 10.1002/path.1579.

引用本文的文献

1
Superficial Angiomyxoma Revisited.复发性浅表血管黏液瘤
In Vivo. 2025 Sep-Oct;39(5):2505-2511. doi: 10.21873/invivo.14053.
2
PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma.PPARG在高分化和去分化脂肪肉瘤中调控脂肪生成分化和细胞状态可塑性。
bioRxiv. 2025 Jul 21:2025.07.16.665211. doi: 10.1101/2025.07.16.665211.
3
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas.POLE上调和高效DNA修复是CIC::DUX4肉瘤的特征。

本文引用的文献

1
A census of amplified and overexpressed human cancer genes.人类癌症基因扩增和过表达的普查。
Nat Rev Cancer. 2010 Jan;10(1):59-64. doi: 10.1038/nrc2771.
2
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
3
Cell cycle, CDKs and cancer: a changing paradigm.细胞周期、细胞周期蛋白依赖性激酶与癌症:不断变化的范式
NPJ Precis Oncol. 2025 Jun 20;9(1):199. doi: 10.1038/s41698-025-00985-8.
4
Intratumoral heterogeneity of cancer driver genomic alterations in myxoid liposarcomas.黏液样脂肪肉瘤中癌症驱动基因改变的肿瘤内异质性
Cancer. 2025 Jun 15;131(12):e35937. doi: 10.1002/cncr.35937.
5
Challenges and hope: latest research trends in the clinical treatment and prognosis of liposarcoma.挑战与希望:脂肪肉瘤临床治疗与预后的最新研究趋势
Front Pharmacol. 2025 May 12;16:1529755. doi: 10.3389/fphar.2025.1529755. eCollection 2025.
6
Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value.去分化脂肪肉瘤中脂肪生成基因增强子的表观遗传破坏及其治疗价值。
Front Oncol. 2025 Apr 30;15:1419877. doi: 10.3389/fonc.2025.1419877. eCollection 2025.
7
Domain-specific embeddings uncover latent genetics knowledge.特定领域的嵌入揭示潜在的遗传学知识。
bioRxiv. 2025 Mar 19:2025.03.17.643817. doi: 10.1101/2025.03.17.643817.
8
Mining TCGA to reveal immunotherapy-related genes for soft tissue sarcoma.挖掘癌症基因组图谱(TCGA)以揭示软组织肉瘤的免疫治疗相关基因。
Medicine (Baltimore). 2025 Feb 28;104(9):e41392. doi: 10.1097/MD.0000000000041392.
9
Identification of potential genes associated with metastasis in osteosarcoma: an integrated bioinformatics analysis.骨肉瘤中与转移相关潜在基因的鉴定:一项综合生物信息学分析
Musculoskelet Surg. 2025 Feb 25. doi: 10.1007/s12306-025-00891-z.
10
A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation.METTL1在tRNA氨基酰化和致癌转化中不依赖甲基转移酶的作用。
Mol Cell. 2025 Mar 6;85(5):948-961.e11. doi: 10.1016/j.molcel.2025.01.003. Epub 2025 Jan 31.
Nat Rev Cancer. 2009 Mar;9(3):153-66. doi: 10.1038/nrc2602.
4
Highly parallel identification of essential genes in cancer cells.癌细胞中必需基因的高度平行鉴定。
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20380-5. doi: 10.1073/pnas.0810485105. Epub 2008 Dec 17.
5
Somatic mutations affect key pathways in lung adenocarcinoma.体细胞突变影响肺腺癌的关键通路。
Nature. 2008 Oct 23;455(7216):1069-75. doi: 10.1038/nature07423.
6
Drug discovery approaches targeting the PI3K/Akt pathway in cancer.针对癌症中PI3K/Akt信号通路的药物发现方法。
Oncogene. 2008 Sep 18;27(41):5511-26. doi: 10.1038/onc.2008.246.
7
PI3K pathway alterations in cancer: variations on a theme.癌症中PI3K信号通路的改变:同一主题的变体
Oncogene. 2008 Sep 18;27(41):5497-510. doi: 10.1038/onc.2008.245.
8
Functional copy-number alterations in cancer.癌症中的功能性拷贝数改变
PLoS One. 2008 Sep 11;3(9):e3179. doi: 10.1371/journal.pone.0003179.
9
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.全面的基因组特征分析确定了人类胶质母细胞瘤的基因和核心通路。
Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4.
10
Drug-sensitive FGFR2 mutations in endometrial carcinoma.子宫内膜癌中的药物敏感性成纤维细胞生长因子受体2(FGFR2)突变
Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8713-7. doi: 10.1073/pnas.0803379105. Epub 2008 Jun 13.